Collections In The Future Will Be Electronic

Three weeks ago I sat in a small room with fellow faculty members at the University of North Carolina who serve with me on the administrative board of our library. At that meeting we voted to cancel 551 journal subscriptions. Over the previous 12 months we had canceled an additional 500 subscriptions as part of our ongoing serial review program. We had little choice. Already stagnant budgets coupled with dramatic increases in subscription prices had cut the number of books we could purchase in

Written byRobert Peet
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Three weeks ago I sat in a small room with fellow faculty members at the University of North Carolina who serve with me on the administrative board of our library. At that meeting we voted to cancel 551 journal subscriptions. Over the previous 12 months we had canceled an additional 500 subscriptions as part of our ongoing serial review program. We had little choice. Already stagnant budgets coupled with dramatic increases in subscription prices had cut the number of books we could purchase in a year to half the number we had purchased only eight years before. If we were to continue to purchase books at all, expenditures for journal subscriptions had to be slashed.

At our neighboring institution, North Carolina State University, the situation was even more grim, because there a stronger emphasis on science has caused serials to make up a larger portion of the materials budget. Book ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies